Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor

被引:30
作者
Kim, Woo-Jin [1 ,2 ]
Kim, Sunmin [1 ]
Choi, Hayoung [1 ]
Chang, Jinsun [1 ]
Shin, Hong-Joon [1 ,2 ]
Park, Cheol-Kyu [1 ,2 ]
Oh, In-Jae [1 ,2 ]
Kim, Kyu-Sik [1 ,2 ]
Kim, Young-Chul [1 ,2 ]
Choi, Yoo-Duk [2 ,3 ]
机构
[1] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Lung & Esophageal Canc Clin, Jeonnam, South Korea
[3] Chonnam Natl Univ, Sch Med, Dept Pathol, Gwangju, South Korea
关键词
Drug resistance; epidermal growth factor receptor; small cell carcinoma; transformation; EGFR MUTATION; CANCER; ADENOCARCINOMA; RESISTANCE;
D O I
10.1111/1759-7714.12217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several cases of acquired resistance in patients with activating epidermal growth factor receptor (EGFR) mutation have been reported. However, rare clinical cases exist of a transformation to small cell lung cancer (SCLC) following treatment with EGFR-tyrosine kinase inhibitors (TKIs). We report a case of non-small cell lung cancer (NSCLC) with L858R mutation at the time of diagnosis. After failure of EGFR-TKI therapy, we performed additional histopathologic examinations. We confirmed that the patient had a histological transformation from NSCLC to SCLC. We performed chemotherapy with etoposide and cisplatin against the SCLC and radiologic findings were improved.
引用
收藏
页码:800 / 804
页数:5
相关论文
共 8 条
[1]   Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor [J].
Chang, Youjin ;
Kim, Seon Ye ;
Choi, Yun Jung ;
So, Kwang Sup ;
Rho, Jin Kyung ;
Kim, Woo Sung ;
Lee, Jae Cheol ;
Chung, Jin-Haeng ;
Choi, Chang-Min .
TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (03) :95-103
[2]   EGFR mutation and resistance of non-small-cell lung cancer to gefitinib [J].
Kobayashi, S ;
Boggon, TJ ;
Dayaram, T ;
Janne, PA ;
Kocher, O ;
Meyerson, M ;
Johnson, BE ;
Eck, MJ ;
Tenen, DG ;
Halmos, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :786-792
[3]   Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor [J].
Lee, Jae Cheol ;
Jang, Seung Hun ;
Lee, Kye Young ;
Kim, Young-Chul .
CANCER RESEARCH AND TREATMENT, 2013, 45 (02) :79-85
[4]   Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation [J].
Morinaga, Ryotaro ;
Okamoto, Isamu ;
Furuta, Kazuyuki ;
Kawano, Yukiko ;
Sekijima, Masaru ;
Dote, Kensaku ;
Satou, Takao ;
Nishio, Kazuto ;
Fukuoka, Masahiro ;
Nakagawa, Kazuhiko .
LUNG CANCER, 2007, 58 (03) :411-413
[5]   Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: Current knowledge and future directions [J].
Pao, W ;
Miller, VA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2556-2568
[6]   Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma [J].
Watanabe, Satoshi ;
Sone, Takashi ;
Matsui, Tomoharu ;
Yamamura, Kenta ;
Tani, Mayuko ;
Okazaki, Akihito ;
Kurokawa, Koji ;
Tambo, Yuichi ;
Takato, Hazuki ;
Ohkura, Noriyuki ;
Waseda, Yuko ;
Katayama, Nobuyuki ;
Kasahara, Kazuo .
LUNG CANCER, 2013, 82 (02) :370-372
[7]   Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers [J].
Yu, Helena A. ;
Arcila, Maria E. ;
Rekhtman, Natasha ;
Sima, Camelia S. ;
Zakowski, Maureen F. ;
Pao, William ;
Kris, Mark G. ;
Miller, Vincent A. ;
Ladanyi, Marc ;
Riely, Gregory J. .
CLINICAL CANCER RESEARCH, 2013, 19 (08) :2240-2247
[8]   Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma? [J].
Zhang, Yan ;
Li, Xiao-Yu ;
Tang, Yuan ;
Xu, Yong ;
Guo, Wen-Hao ;
Li, Yan-Chu ;
Liu, Xiao-Ke ;
Huang, Chu-Ying ;
Wang, Yong-Sheng ;
Wei, Yu-Quan .
LUNG CANCER, 2013, 81 (02) :302-305